stockrowWest Pharmaceutical Services, Inc.
WST Healthcare Medical Instruments & Supplies
West Pharmaceutical Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.1 billion, up 6.25% from fiscal 2024.
- Revenue
- +8.69%
- EPS
- +56.7%
- Free cash flow
- +12.3%
- Total debt
- +0.10%
Quarter to September 2026, against a year earlier
Follow WST
Alert me
West Pharmaceutical Services, Inc. (WST) Return on assets
West Pharmaceutical Services, Inc.'s return on assets over the twelve months to 30 September 2026 was 15.7%, up 3.2 percentage points from fiscal 2025 (12.5%). Over the past ten years it has ranged from 5.68% (fiscal 2015) to 21.7% (fiscal 2021); the current reading is higher than 55% of that period. That is above the Medical Instruments & Supplies industry median of 0.00% and above the Healthcare sector median of −29.3%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | 12.5% | (0.71) |
| FY2024 | 13.2% | (2.75) |
| FY2023 | 15.9% | (0.97) |
| FY2022 | 16.9% | (4.76) |
| FY2021 | 21.7% | 8.19 |
| FY2020 | 13.5% | 2.29 |
| FY2019 | 11.2% | 0.42 |
| FY2018 | 10.8% | 2.35 |
| FY2017 | 8.42% | 0.00 |
| FY2016 | 8.42% | 2.74 |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| RMD ResMed Inc. compare | 19.3% |
| WST West Pharmaceutical Services, Inc. | 15.7% |
| ALGN Align Technology, Inc. compare | 7.71% |
| COO The Cooper Companies, Inc. compare | 4.55% |
| ALC Alcon compare | 2.06% |
| BDX Becton, Dickinson and Company compare | 1.78% |
| MDLN Medline Inc. compare | 1.49% |
| SOLV Solventum Corporation compare | 1.11% |
| BAX Baxter International Inc. compare | −3.57% |
| Medical Instruments & Supplies industry median | 0.00% |
| Healthcare sector median | −29.3% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on WST
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement